Recruiting Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab NCT04014374 Conditions ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more Locations CIBMTR — Milwaukee, Wisconsin, United States View Trial Details
